The administration of drugs is a key strategy in pharmacotherapy to treat diseases. Drugs are typically developed to modulate the function of specific proteins, which are directly associated with particular disease states. Nonetheless, recent studies suggest that protein-drug interactions are rather promiscuous and the majority of pharmaceuticals exhibit activity against multiple, often unrelated proteins. Certainly, the lack of selectivity often leads to drug side effects; on the other hand, these polypharmacological attributes can be used to develop drugs acting on multiple targets within a unique disease pathway, as well as to identify new targets for existing drugs, which is known as drug repositioning. To support drug development and repurposing, we developed eMatchSite, a new approach to detect those binding sites having the capability to bind similar compounds. eMatchSite is available as a standalone software and a webserver at http://www. brylinski.org/ematchsite.
Introduction
Network analysis of interactions between proteins and small organic compounds is broadly applicable throughout the drug development process in both biology and chemistry. The classical picture of selective ligand binding has been challenged by experimental and computational studies, which strongly suggest that the space of protein-ligand interactions is dense and highly connected [1] . Several independent studies were conducted to estimate the promiscuity of protein-ligand interactions. For example, a largescale across-target activity analysis carried out for 189,807 active compounds from PubChem [2] shows that the majority (62%) of them exhibit activity against multiple, often unrelated targets [3] . Another study investigating a set of 3138 compounds against 79 targets reported that 47% of the compounds can be classified as "promiscuous" and 24% as "highly promiscuous" with multiple targets hit at an IC 50 of <10 μM [4] . Furthermore, a thorough survey of a network of 5215 protein-ligand interactions connecting 829 compounds with 557 targets estimated that the average number of target proteins per ligand is 6.3 [5] . Although this notable binding promiscuity may complicate drug development, it also creates appealing opportunities for polypharmacology and drug repurposing.
Classical algorithms detecting relationships between proteins widely used in bioinformatics cannot be applied to investigate drug cross-reactivity because many compounds bind to multiple proteins that are totally unrelated to each other at the global sequence and structure levels [6, 7] . Therefore, a comprehensive analysis of the protein-drug interaction space requires a different set of tools. A direct comparison of binding sites is capable of describing ligand binding at the molecular level to provide useful insights into the compound mode of action [8] . Most algorithms for binding site matching fall into two categories: alignment-free and alignmentbased methods. Geometric hashing is a typical example of the alignment-free approach; it measures the overall similarity of two binding sites, however, without providing any structural information on putative ligand binding modes and molecular interactions with target proteins [9] . In contrast, methods based on binding site alignments elucidate why two sites are similar, identify the sets of atoms/residues that contribute to the similarity, and describe putative ligand binding modes. SuMo (Surfing the Molecules) was one of the first approaches to use a residue-independent stereochemical group description combined with a fast, graph-based algorithm to compare protein structures and substructures [10] . Another method, SiteEngine, matches low-resolution protein surfaces constructed by converting triangles of physicochemical properties into a discrete set of chemically important points [11] . Finally, SOIPPA performs sequence order-independent profile-profile alignments of binding pockets using a coarse-grained representation of protein structures [12] .
Despite encouraging progress in the development of sequence order-independent algorithms for ligand binding site alignment, many of these approaches perform well only against high-quality binding sites extracted from experimental protein structures. This insufficient accuracy hinders the reconstruction of protein-drug interaction networks across proteomes; thus, it is imperative to develop new approaches insensitive to structural deformation in ligand binding regions of protein models. To mitigate this issue, we developed eMatchSite, a new algorithm that performs sequence order-independent local binding site alignments using computergenerated protein models [13] . A key feature responsible for its high performance is the extensive use of evolutionary information that can be extracted even from weakly homologous templates complexed with ligands. In addition, eMatchSite provides a calibrated significance score to identify those pockets capable of binding chemically similar ligands regardless of any global sequence and structure similarities between the target proteins. Benchmarking calculations demonstrate that eMatchSite outperforms other algorithms constructing sequence order-independent alignments of ligand binding sites. Importantly, eMatchSite maintains its high prediction accuracy against protein models; therefore, it opens up the possibility of investigating drug-protein interactions for complete proteomes with prospective systems-level applications in polypharmacology and rational drug repositioning.
Materials

Input Data
Input data for eMatchSite consist of two protein structures in the Protein Data Bank (PDB) format, whose ligand binding sites were annotated by eFindSite (see Note 1). eFindSite is a ligand binding site prediction and virtual screening algorithm that detects common ligand binding sites in a set of evolutionarily related proteins identified by meta-threading [14, 15] . In order to perform binding site annotation with eFindSite, users can employ either its standalone version or webserver located at http://www.brylinski.org/efindsite (see Note 2). It is noteworthy that both eFindSite and eMatchSite work well not only with experimentally solved structures, but also with computer-generated protein models (see Note 3). Alternatively, users can specify the path to individual data files from command line. For example, the following arguments can be used to provide the location of target structures:
Programs
-structureA first_pdb, where first_pdb is the first protein in the PDB format,
-structureB second_pdb, where second_pdb is the second protein in the PDB format.
The path to other input data can be specified in a similar way.
Output Options
-o output_name, where output_name is a PDB file containing all results from eMatchSite.
Virtual Screening Options
-m score_func, where score_func is a scoring function to perform ligand-based virtual screening. Currently, implemented functions include single and combined scores (see [15] for details):
Single scoring functions: Combined scoring functions: sum-data fusion using the sum rule (default), max-data fusion using the max rule, min-data fusion using the min rule, svm-machine learning using Support Vector Machines.
Output Files
eMatchSite outputs a single file that contains (1) numerical scores for the constructed alignment of binding sites, (2) aligned residue pairs with the corresponding Cα-Cα distances, (3) transformation matrices to superpose the second protein onto the first protein, and (4) the coordinates of the second protein upon the superposition of two binding sites.
Web Sites
The webserver available at http://www.brylinski.org/ematchsite provides a convenient interface to run eMatchSite. In addition, the website provides a standalone package that can be installed locally for high-throughput computations, benchmarking datasets and results for an easy comparison with other algorithms constructing local alignments of binding sites, as well as a detailed manual and tutorial to help run eMatchSite.
Methods
Web Submission Form
The submission form for the eMatchSite webserver requires two target pockets annotated by eFindSite. Fig. 1 shows that users need to provide a 10-digit eFindSite ticket for each target and specify the pocket number if multiple pockets are identified in the target structure. In addition, each submission requires a unique "Job ID" and, optionally, an email address where the results will be sent. If a user prefers not to use email notifications, the automatically generated 10-digit ticket for each submission can be used to check the job status using the "Job Tracking" form in the right sidebar at http://www.brylinski.org.
Result Page
Results generated by the eMatchSite webserver are arranged into several sections, as shown in Fig. 2 . The first section (Fig. 2a) gives the general information including the "Job ID," the "eMatchSite ticket" that can be used to retrieve the results within a month from the submission date, and the identifiers of protein targets. Further, three numerical scores for the local alignment of binding sites are provided, including the alignment score ranging from 0 to 1, the Fig. 1 Web submission form for the eMatchSite server. Fields marked with red asterisks are mandatory number of aligned residues, and the Cα-RMSD calculated upon the superposition of target pockets. Based on the alignment score, the similarity of the pair of target pockets is determined. The superposition of target binding sites is visualized using the AstexViewer web applet [16] (Fig. 2b) . Here, protein structures are displayed as transparent cartoons, whereas binding residues are shown as solid sticks. Moreover, individual aligned residue pairs can be highlighted and labeled using radio buttons. The next section contains a table showing the local alignment of binding sites (Fig. 2c) . For each aligned residue pair, the Cα-Cα distance measured upon the local superposition, as well as the Cα-Cα distance and the probability score estimated by machine learning are listed. Finally, the last section provides a download link to the output file generated by eMatchSite (Fig. 2d) . Note that the results are kept on the server for 1 month only, after which all data associated with a particular submission will be deleted. However, we keep one sample job for each webserver, so that users can quickly find out whether the webservers offer a desired functionality. These sample results can be accessed anytime either by clicking on links provided in the submission web forms, e. g., "This server is running eMatchSite v1.0. Click here to see some sample results," or by using 10-digit tickets, "Futermylok" for eFindSite and "Mamlasiaty" for eMatchSite, in the "Job Tracking" form in the right sidebar.
Case Studies
We selected a couple of illustrative examples to demonstrate how eMatchSite detects those pockets binding similar ligands in non-homologous proteins by constructing the sequence-order independent alignments of their binding sites. The primary target is benzoylformate decarboxylase (BFD) from Pseudomonas putida complexed with thiamin-2-thiazolone diphosphate (PDB-ID: 1yno) [17] . BFD belongs to the family of enzymes dependent on thiamine diphosphate and catalyzes the conversion of benzoylformate to benzaldehyde and carbon dioxide. Thiamin-2-thiazolone diphosphate (ThTDP) is a potent inhibitor of several thiamindependent enzymes that initiate the catalyzed reactions by forming a covalent adduct between the substrate and thiamin diphosphate (ThDP) through the C2 atom of the thiazolium ring [18] . In ThTDP, the proton on C2 is replaced with an oxygen atom to effectively inactivate thiamin-dependent enzymes. ThTDP binds to its target enzymes with an essentially identical binding mode as ThDP, but at a 10-1000 higher affinity compared to ThDP [19] [20] [21] . In addition to the primary target BFD, we selected two offtargets known to bind ThTDP, oxalyl-coenzyme A decarboxylase from Oxalobacter formigenes (OXC, PDB-ID: 2c31) [22] and the dehydrogenase/decarboxylase component of the human branched-chain α-ketoacid dehydrogenase complex (hE1b, PDB-ID: 2bff) [23] . OXC plays an important role in the catabolism of the highly toxic compound oxalate and it is structurally similar to BFD with a TM-score [24] of 0.85 despite a low sequence identity of 25% (Table 1 , Global similarity). hE1b, which catalyzes the decarboxylation of branched-chain α-ketoacids derived from the amino acids leucine, isoleucine, and valine, shares neither sequence nor structure similarity with BFD (Table 1, Global similarity). Both off-targets represent a challenge to local binding site alignment algorithms due to their low sequence homology with the primary target, BFD. eMatchSite requires binding sites and residues to be annotated by eFindSite; therefore, eFindSite webserver at http://www. brylinski.org/efindsite was used to identify binding sites in the crystal structures of BFD, OXC, and hE1b. The results are shown in Fig. 3 . A binding site for ThTDP in the primary target BFD was identified with a 95% confidence; the Matthews correlation coefficient (MCC) calculated over binding residues is as high as 0.89 (Fig. 3a) . The prediction confidence for off-targets OXC and hE1b is 94% and 93%, respectively. MCC calculated for binding residues identified in OXC is 0.78 (Fig. 3b) and 0.88 for hE1b (Fig. 3c) . Note that bound ThTDP ligands are shown in Fig. 3 only to assess the accuracy of binding pocket prediction with eFindSite, which detects and annotates binding sites in ligand-free protein structures [14, 15] .
Despite a low homology between the primary target and offtargets, binding sites in both OXC and hE1b are correctly recognized by eMatchSite as highly similar to the ThTDP-binding site in BFD, indicated by a confidence of 93% and 94%, respectively. Using data reported by eMatchSite, we can analyze how these high similarity scores were calculated. eMatchSite constructs sequence orderindependent alignments using machine learning with Support Vector Regression techniques (SVR). Specifically, it assigns SVR scores to all possible combinations of binding residues in the first (target) and the second (off-target) protein. Then, it applies the KuhnMunkres algorithm [25, 26] to identify a unique set of residue pairs that give the shortest overall distance between their Cα atoms. The Kuhn-Munkres algorithm, also known as the Hungarian method, belongs to the complexity class P [27] , efficiently solving combinatorial assignment problems in polynomial time. In eMatchSite, this algorithm produces sequence orderindependent alignments whose sum of Cα-Cα distances is guaranteed to be the smallest among all possible alignment combinations.
Clearly, a high correlation between Cα-Cα distances estimated by machine learning (SVR scores) and real distances calculated upon the superposition of bound ThTDP molecules is a critical factor to produce correct alignments. Encouragingly, light gray circles in Fig. 4 demonstrate that the machine learning model implemented in eMatchSite accurately predicts Cα-Cα distances; the Pearson correlation coefficients for BFD/OXC (Fig. 4a) and BFD/hE1b (Fig. 4b) are as high as 0.98 and 0.94, respectively. As a consequence, the unique sets of residue pairs selected by the KuhnMunkres algorithm to yield the shortest overall Cα-Cα distance actually correspond to the reference alignments constructed by superposing ThTDP molecules bound to the primary target and off-targets (dark gray triangles in Fig. 4 ). Bear in mind that ThTDP ligands bound to BFD, OXC, and hE1b are used only to validate alignments generated by eMatchSite that employs binding pockets annotated by eFindSite in ligand-free target structures.
Geometrical and physicochemical matching of binding sites in eMatchSite is supported by a chemical correlation, which was originally devised to study the inhibitor cross-reactivity within the human kinome [28] . In essence, a fingerprint-based virtual screening is performed against two pockets using a nonredundant subset of the ZINC library [29] comprising 23,659 molecules. Subsequently, the Kendall τ rank correlation coefficient [30] is calculated for the ranked compounds under the assumption that virtual screening should yield a similar ranking for those pockets binding similar compounds. Indeed, Fig. 5 shows a high chemical correlation between binding sites in the primary and off-targets selected for this case study. The Kendall τ rank correlation coefficient is 0.98 between BFD and OXC (Fig. 5a) , and 0.81 between BFD and hE1b (Fig. 5b) .
Sequence order-independent alignments constructed by eMatchSite for BFD/OXC and BFD/hE1b are reported in Table 2 . Sixteen residues are involved in the alignment between BFD and OXC, and 15 residues in that between BFD and hE1b; in both cases, the distances between the aligned Cα atoms upon the superposition of binding sites are fairly short. Binding pockets in off-targets superposed onto the pocket in the primary target structure are shown in Fig. 6 . Table 1 (Local similarity) reports the RMSD calculated over Cα atoms of 3.18 Å for BFD/OXC (Fig. 6a ) and 2.72 Å for BFD/hE1b (Fig. 6b) . The accuracy of alignments constructed by eMatchSite can be evaluated by an RMSD calculated over the non-hydrogen atoms of ThTDP molecules upon the superposition of binding residues. Encouragingly, Table 1 (Local similarity) shows that the ligand RMSD is as low as 0.88 Å for BFD/OXC (Fig. 6c) and 0.89 Å for BFD/hE1b (Fig. 6b) . Overall, these two case studies demonstrate that eMatchSite effectively recognizes binding site similarity and constructs biologically correct sequence order-independent alignments for pockets inferred by eFindSite from ligand-free protein structures. 4 Notes 1. Although the current version of eMatchSite requires ligand binding sites to be annotated by eFindSite, we are working on other prediction protocols to compare binding pockets detected by purely geometrical methods. Nonetheless, eFindSite was demonstrated to outperform many other algorithms in large-scale benchmarking calculations; therefore, the combination of eFindSite/eMatchSite works best in detecting similar binding sites across large datasets of protein structures. Since eFindSite typically detects more than one site for the majority of proteins, users may want to specify the binding site of interest if they plan to run eMatchSite for a handful of targets. In large-scale applications, the top-ranked binding sites should be used by default because eFindSite ranks the best pocket at rank 1 in about 80% of the cases. 3. Both eFindSite and eMatchSite have been designed to work not only with experimental ligand-bound (holo) and ligand-free (apo) target structures, but also with computer-generated protein models. Compared to crystal structures, the accuracy of eFindSite predicting binding residues in high-and moderatequality structure models decreases only by 4.2% and 9.9%, respectively [14] . Similarly, eMatchSite also maintains its capability to construct highly accurate alignments when protein models are used. Depending on the model quality, the percentage of correctly aligned binding sites is only 4-9% lower than those aligned using crystal structures [13] . On that account, binding site similarities can be effectively detected using homology models generated across proteomes by contemporary protein structure prediction techniques.
